TECPR2 Observational Study

NCT04485221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2023-09-11

No results posted yet for this study

Summary

The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.

Conditions

  • TECPR2

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Eligibility

Min Age
18 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2023-08-17
Completion
2023-08-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04485221 on ClinicalTrials.gov